Brian Singerman

Brian Singerman (an haife shi 1976 or 1977  name="konrad2017"> ) ɗan jari-hujja ne na Amurka kuma ɗan kasuwa. Shi abokin tarayya ne na Founders Fund, wani kamfani mai jari-hujja da ke San Francisco wanda ke da sama da dala biliyan 11 a ƙarƙashin gudanarwa. 

 Rayuwar farko da ilimi 
Singerman ya kammala karatunsa daga Jami'ar Stanford a shekarar 1999 da digirin farko a fannin Kimiyyar Kwamfuta.  name="konrad2017">"Move Over, Peter Thiel -- How Brian Singerman Became Founders Fund's Top VC". Forbes. Retrieved 2 August 2023. Bayan Stanford, ya shiga kamfanin yanar gizo na kama-da-wane a can a matsayin injiniyan software. 

 Sana'a 

 Google 
A shekara ta 2004, Singerman ya shiga Google inda ya shafe shekaru huɗu a matsayin injiniya kuma babban jami'i. A Google, ya kafa shafin yanar gizo na sirri, iGoogle . name="Inc.">

A lokacin da yake aiki a Google, Singerman ya fara aikinsa na saka hannun jari, inda ya ƙaddamar da asusun dala miliyan 1 mai suna XGYC Fund, a taƙaice "tsohon Google, Y Combinator." 

 Asusun Masu Kafawa 
A shekara ta 2008, Singerman ya shiga Asusun Founders, inda yake aiki tare da Peter Thiel da Ken Howery .  Ya mai da hankali kan kiwon lafiya, fasahar kere-kere, kwamfuta mai sauƙin ɗauka, da kuma na'urorin robot.

Singerman ya kasance daraktan gudanarwa na kamfanoni da dama, ciki har da Affirm, Cloud9, Emerald Therapeutics, The Long-Term Stock Exchange, Oscar Health, da Postmates. Bugu da ƙari, ya yi aiki a matsayin mai lura da harkokin gudanarwa na Airbnb, Forward, da Wish. 

A ranar 3 ga Disamba, 2024, Singerman ya sanar da sauya shekarsa zuwa matsayin abokin tarayya na meritus a Asusun Founders, yana shirin ci gaba da zama mai ba da shawara kan dabarun aiki tare da fifita sabon daidaiton aiki da rayuwa. 

 Manyan jarin da aka zuba 
Ɗaya daga cikin manyan jarin da Singerman ya zuba shine na Stemcentrx, wani kamfanin fasahar kere-kere da ke mai da hankali kan magungunan ciwon daji. A watan Afrilun 2016, AbbVie ya sayi Stemcentrx a cikin wata ciniki da ta kai dala biliyan 10.2, wanda hakan ya nuna mafi girman fita daga cikin ayyukansa a tarihin Asusun Tallafawa. Duk da haka, a cikin 2019, AbbVie ya rufe Stemcentrx bayan da babban maganin kansa, Rova-T, ya kasa yin tasiri ga placebo a gwajin asibiti na Mataki na 3.

Ya kuma shiga cikin saka hannun jari a cikin Oculus VR (wanda Facebook ya saya) da Postmates (wanda Uber ya saya). 

 Rayuwa ta sirri 
Singerman yana zaune a San Francisco, California . 

 Manazarta 

Rukuni:Rayayyun mutane